TABLE 3.
Unadjusted between‐group analyses for primary and secondary outcomes
| Mindful eating + TAU Mean (SD) | TAU Mean (SD) | Mindful eating + TAU versus TAU | |||
|---|---|---|---|---|---|
| d | Z (p) | B (95% CI) | |||
| DEBQ ‘Emotional eating’ | n = 39 | n = 33 | |||
| Baseline | 2.65 (0.87) | 1.97 (0.66) | |||
| Post‐treatment † | 2.40 (0.63) | 2.07 (0.70) | 0.35 | −2.78 (0.006) | −0.27 (−0.46 to −0.08) |
| Follow‐up | 2.27 (0.64) | 2.19 (0.68) | 0.69 | −4.17 (<0.001) | −0.53 (−0.78 to −0.28) |
| DEBQ ‘External eating’ | n = 40 | n = 35 | |||
| Baseline | 2.89 (0.66) | 2.36 (0.59) | |||
| Post‐treatment | 2.77 (0.52) | 2.43 (0.54) | 0.31 | −2.11 (0.035) | −0.19 (−0.036 to −0.01) |
| Follow‐up | 2.55 (0.46) | 2.51 (0.58) | 0.85 | −5.68 (<0.001) | −0.50 (−0.67 to −0.33) |
| DEBQ ‘Restrained eating’ | n = 35 | n = 34 | |||
| Baseline | 2.73 (0.60) | 2.56 (0.80) | |||
| Post‐treatment | 2.82 (0.62) | 2.58 (0.78) | 0.03 | 0.34 (0.735) | 0.04 (−0.18–0.25) |
| Follow‐up | 2.73 (0.50) | 2.54 (0.78) | 0.12 | −0.26 (0.792) | −0.03 (−0.24 to 0.18) |
| BITE symptoms | n = 40 | n = 35 | |||
| Baseline | 7.38 (5.96) | 5.49 (4.33) | |||
| Post‐treatment | 8.67 (4.79) | 7.12 (3.87) | 0.02 | −0.50 (0.620) | −0.45 (−2.23–1.33) |
| Follow‐up | 5.58 (5.40) | 4.89 (3.46) | 0.14 | −1.30 (0.192) | −1.18 (−2.95 to 0.59) |
| BITE severity | n = 40 | n = 35 | |||
| Baseline | 2.78 (1.79) | 2.57 (1.67) | |||
| Post‐treatment | 2.69 (1.53) | 2.40 (1.67) | 0.06 | 0.14 (0.888) | 0.06 (−0.71–0.82) |
| Follow‐up | 1.97 (1.80) | 2.89 (2.73) | 0.65 | −2.89 (0.004) | −1.13 (−1.89 to −0.36) |
| BITE item 27 | n = 40 | n = 35 | |||
| Baseline | 2.35 (1.42) | 1.97 (1.40) | |||
| Post‐treatment | 2.11 (1.29) | 2.00 (1.41) | 0.14 | −0.87 (0.385) | −0.26 (−0.84 to 0.32) |
| Follow‐up | 1.63 (1.37) | 2.20 (1.69) | 0.53 | −3.26 (0.001) | −0.96 (−1.54 to −0.38) |
| EAT‐26 dieting | n = 40 | n = 35 | |||
| Baseline | 7.93 (5.92) | 10.00 (5.91) | |||
| Post‐treatment | 7.79 (6.95) | 9.76 (5.93) | 0.01 | −0.12 (0.903) | −0.13 (−2.25–1.99) |
| Follow‐up | 7.75 (6.09) | 9.34 (5.92) | 0.11 | 0.19 (0.852) | 0.20 (−1.89–2.28) |
| EAT‐26 bulimia | n = 40 | n = 35 | |||
| Baseline | 1.33 (1.80) | 1.80 (2.41) | |||
| Post‐treatment | 1.15 (1.35) | 1.62 (2.22) | 0.08 | 0.20 (0.840) | 0.07 (−0.65–0.80) |
| Follow‐up | 0.78 (1.31) | 1.57 (1.96) | 0.06 | −0.84 (0.399) | −0.31 (−1.02–0.41) |
| EAT‐26 oral control | n = 40 | n = 35 | |||
| Baseline | 2.15 (2.23) | 3.00 (2.61) | |||
| Post‐treatment | 1.97 (2.43) | 2.76 (2.57) | 0.08 | −0.25 (0.803) | −0.10 (−0.89 to 0.69) |
| Follow‐up | 2.00 (2.19) | 2.57 (2.36) | 0.02 | 0.33 (0.745) | 0.13 (−0.64–0.90) |
| GAD‐7 | n = 41 | n = 35 | |||
| Baseline | 3.49 (4.51) | 4.00 (3.96) | |||
| Follow‐up | 2.66 (3.98) | 2.86 (4.64) | 0.07 | 0.26 (0.797) | 0.29 (−1.93–2.52) |
| PHQ9 | n = 41 | n = 35 | |||
| Baseline | 4.00 (5.34) | 2.89 (2.45) | |||
| Follow‐up | 2.49 (3.39) | 2.96 (4.19) | 0.36 | −1.48 (0.139) | −1.62 (−3.78 to 0.53) |
Note: † Main outcome at the primary endpoint. In bold, statistically significant results.